Dunyagoz Eye Hospital Istanbul Etiler
Retinoblastoma treatment cost in Turkey typically includes complex diagnostics of retinoblastoma from $700 to $900 and primary interventions like enucleation of eye ranging from $5,400 to $8,500. Total expenses depend on the tumor stage, necessary chemotherapy cycles, and the selected facility tier. International patients generally save 50-80% compared to the United States. Top treatment destinations include Istanbul, Izmir, and Ankara.
Typical Retinoblastoma Treatment Costs in Turkey
Bookimed Expert Insight: Advanced ocular oncology cases benefit from multidisciplinary care at JCI-accredited centers. Anadolu Medical Center provides high-value pediatric oncology through its Johns Hopkins affiliation. For specialized surgical needs, Associate Professor Muhammet Derda Ozer offers extensive experience with over 25,000 vitreoretinal procedures. Memorial Şişli Hospital is ideal for complex staging requiring full pediatric oncology support. Families often choose Dunyagoz for accessible eye care packages in a facility treating 66,000 international patients annually.
| Turkey | Austria | Spain | |
| Radiation therapy for colorectal cancer | from $7,000 | from $12,000 | from $10,000 |
| Photocoagulation | from $250 | from $750 | from $800 |
| High intensity focused ultrasound ablation (HIFU) | from $4,000 | from $12,000 | from $6,000 |
| Enucleation of eye | from $5,400 | from $14,000 | from $8,500 |
| Chemotherapy for breast cancer | from $1,200 | from $15,000 | from $3,500 |
Associate Professor Muhammet Derda Ozer specializes in retinoblastoma with training at Wills Eye Institute, a global leader in ocular oncology.
Professor Dr. Ceyhun Bozkurt specializes in pediatric oncology with a focus on retinoblastoma at Medical Park Bahcelievler Hospital.
Professor Yesim Yildirim specializes in cancer immunotherapy and targeted therapies, with a focus on breast, gastrointestinal, and lung cancers.
Dr. Ahmet Nadir Tosyali is a pediatric surgeon at Anadolu Medical Center in Istanbul. He holds the Turkish Pediatric Surgery Qualification Certificate. Dr. Tosyali treats complex conditions like Wilms tumor, neuroblastoma, and spina bifida. He provides care at a clinic affiliated with Johns Hopkins Medicine.
Dunyagoz Eye Hospital, Anadolu Medical Center, and Memorial Hospitals are leading Turkish centers for retinoblastoma. These facilities combine pediatric oncology with specialized ophthalmology. Many maintain Joint Commission International (JCI) accreditation. Istanbul and Ankara serve as primary hubs for complex ocular oncology care.
Bookimed Expert Insight: While popular hospital brands attract many patients, the highest value for retinoblastoma often lies with specific ocular specialists like Dr. Muhammet Derda Ozer. His experience of 25,000 surgeries exceeds common benchmarks. Such high caseloads are critical for performing eye-sparing procedures safely.
Patient Consensus: Families often emphasize finding a single system that offers combined pediatric oncology and ocular imaging. They note it is important to confirm a hospital has a dedicated retinoblastoma team before traveling.
Advanced retinoblastoma treatments in Turkey include selective intra-arterial chemotherapy (SIAC), intravitreal chemotherapy, and eye-sparing focal therapies. JCI-accredited centers in Istanbul and Ankara utilize cryotherapy and laser photocoagulation. Specialized surgeons perform enucleation with implant insertion for advanced cases to ensure optimal cosmetic results.
Bookimed Expert Insight: Specialist surgeons in Turkey, such as Dr. Muhammet Derda Ozer or Dr. Ahmet Satici, have performed over 20,000 surgeries each. This high volume is critical for retinoblastoma, where precision in globe-sparing techniques or implant placement directly impacts the child's quality of life. Some packages even include 5 days in a 4-star hotel to accommodate necessary follow-up exams.
Patient Consensus: Parents emphasize looking for centers specifically marketing retinoblastoma services rather than general pediatric care. They suggest budgeting 2–4 weeks for stays as treatment plans often shift rapidly between eye-saving methods and surgery.
Families choose Turkey for retinoblastoma care due to survival rates reaching 96%. Many centers provide advanced eye-sparing treatments like intra-arterial chemotherapy and plaque radiotherapy. JCI-accredited facilities offer these therapies at costs significantly lower than Western nations, usually within 1-2 weeks of inquiry.
Bookimed Expert Insight: Retinoblastoma treatment in Turkey is uniquely concentrated in multidisciplinary eye-specialized centers. Clinics like Dunyagoz serve 66,000+ patients annually. Our data shows that while surgical enucleation costs around $6,000, these high-volume centers often provide immediate access to ocular oncologists. This helps families avoid the 3-month waiting lists common in European public health systems.
Patient Consensus: Families note that Turkish hospitals offer a more organized experience for international patients. They appreciate having dedicated translation teams and all oncology services under one roof.
The sequence involves specialized pediatric oncology diagnostics followed by systemic or local therapy. Doctors prioritize eye-sparing methods like intra-arterial chemotherapy or cryotherapy. If the tumor is large, surgeons perform enucleation with implant insertion to ensure safety and provide optimal aesthetic results.
Bookimed Expert Insight: Turkish oncology centers often group complex diagnostics and surgery into single-price packages. While Dr. Muhammet Derda Ozer offers VIP transfers and 5-star hotel stays, Private Bagcilar Safak Hospital focuses on high-volume surgical expertise. These differences show that patients can choose between luxury recovery or high-throughput clinical centers for the same $6,000 cost.
Patient Consensus: Patients note the treatment plan can change quickly based on how the tumor responds. They emphasize confirming if the primary goal is saving the eye or ensuring safe removal.